Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,218 | -16,362 | -12,085 | -16,755 | -10,839 |
| Depreciation Amortization | 69 | 65 | 51 | 535 | 412 |
| Other Working Capital | -325 | -680 | -455 | -352 | -1,294 |
| Other Operating Activity | 10,099 | 9,686 | 9,393 | 3,236 | 1,531 |
| Operating Cash Flow | $-11,374 | $-7,291 | $-3,097 | $-13,336 | $-10,190 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -22 | -21 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-22 | $-21 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,855 | 8,855 | 8,855 | 16,401 | 9,319 |
| Other Financing Activity | -456 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $8,399 | $8,855 | $8,855 | $16,401 | $9,319 |
| Beginning Cash Position | 5,811 | 5,811 | 5,811 | 2,768 | 2,768 |
| End Cash Position | 2,836 | 7,375 | 11,569 | 5,811 | 1,876 |
| Net Cash Flow | $-2,975 | $1,564 | $5,758 | $3,044 | $-892 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,374 | -7,291 | -3,097 | -13,336 | -10,190 |
| Capital Expenditure | N/A | N/A | N/A | -22 | -21 |
| Free Cash Flow | -11,374 | -7,291 | -3,097 | -13,358 | -10,211 |